abemaciclib,anastrozole,letrozole
eli lilly,novartis
['monarch-3', 'abema', 'bcsm', 'abemaciclib']
2nd ia of monarch-3: longer os w/ abemaciclib + nsai but not reaching the predefined threshold of significance mos 67.1 vs 54.5 mo. final os analysis expected in 2023 #bcsm #esmo22 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge